Cancer Liquid Biopsy
A minimally invasive method of testing for biomarkers of cancer and other diseases, liquid biopsy can sidestep costly and stressful surgical procedures. All you need are blood or other body fluid samples and sensitive and specific solutions to detect and analyze circulating cell-free DNA (cfDNA), circulating tumor DNA (ctDNA), cell-free miRNA, cancer exosomes and circulating tumor cells (CTCs). QIAGEN offers robust, efficient and streamlined solutions to empower your research through liquid biopsy. From collection through analysis, our solutions help to standardize your processes and advance biomarker discovery for early detection, monitoring or guided treatment with precision medicine.
Get an overview of our dedicated solutions